2024-03-28T14:45:10Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_1E3C16F37527
2024-03-23T01:56:54Z
serval:BIB_1E3C16F37527
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
10.1093/neuonc/noy132
000463915500004
30189035
Mansouri
A.
author
Hachem
L.D.
author
Mansouri
S.
author
Nassiri
F.
author
Laperriere
N.J.
author
Xia
D.
author
Lindeman
N.I.
author
Wen
P.Y.
author
Chakravarti
A.
author
Mehta
M.P.
author
Hegi
M.E.
author
Stupp
R.
author
Aldape
K.D.
author
Zadeh
G.
author
article
review
2019-02-14
Neuro-oncology
1523-5866
1522-8517
journal
21
2
167-178
DNA Methylation
DNA Modification Methylases/genetics
DNA Repair Enzymes/genetics
Gene Expression Regulation, Neoplastic
Glioblastoma/diagnosis
Glioblastoma/genetics
Glioblastoma/therapy
Humans
Prognosis
Promoter Regions, Genetic
Tumor Suppressor Proteins/genetics
MGMT
diagnostic
glioma
methylation
molecular markers
prognostic
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Review
Publication Status: ppublish